Replies to post #4470 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

The bearish item is 2024-2025 guidance, specifically: “…expects to be Adjusted EBITDA positive in 2025.” Many investors probably expected EBIDTA positivity in 2024 and actual (GAAP) profitability in 2025.

[10nisman]

What was the surprise to the market that caused the sell-off? I can't find anything to justify a 30% drop.

The market must be looking at the increased GAAP loss due to the impairment adjustment for exiting the OPUL business.

I added shares in the 11's.